{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-028916","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2026-08-25T20:12:59+00:00","discovered_at":"2026-08-25T20:14:05.044925+00:00","generated_at":"2026-08-25T20:14:10.818839+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vaxart creates two new board committees, appoints members","bullets":["On Aug 21, 2026, board formed Clinical and Regulatory Affairs Committee and Stockholder Engagement Committee.","Dr. James B. Breitmeyer chairs Clinical/Regulatory; Dr. David Wheadon also appointed as member.","W. Mark Watson named Interim Chair of Stockholder Engagement Committee; Steven Lo also a member.","New director to chair Stockholder Engagement Committee per July 1, 2026 Cooperation Agreement.","Committees oversee clinical/regulatory programs and stockholder relations respectively."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-028916","json":"https://secwatch.observer/filing/0001437749-26-028916.json","markdown":"https://secwatch.observer/filing/0001437749-26-028916.md","text":"https://secwatch.observer/filing/0001437749-26-028916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774926028916/0001437749-26-028916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774926028916/vxrt20260824_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-25T20:14:10.818839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}